mecamylamine has been researched along with Consciousness, Loss of in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mukai, A | 1 |
| Irifune, M | 1 |
| Shimizu, Y | 1 |
| Doi, M | 1 |
| Kikuchi, Y | 1 |
| Katayama, S | 1 |
| Oue, K | 1 |
| Yoshida, M | 1 |
| Ago, Y | 1 |
| Okada, Y | 1 |
| Morioka, N | 1 |
| Nakata, Y | 1 |
| Sakai, N | 1 |
1 other study available for mecamylamine and Consciousness, Loss of
| Article | Year |
|---|---|
N-methyl-d-aspartate receptors and glycinergic transmission, respectively, mediate muscle relaxation and immobility of pentobarbital in mice.
Topics: Animals; Dizocilpine Maleate; gamma-Aminobutyric Acid; Mecamylamine; Mice; Pentobarbital; Receptors, | 2023 |